Victor RG, Leonard D, Hess P, et al. Factors Associaed with Hypertension Awareness, Treatment, and Control in Dallas County, Texas, Arch Intern Med. 2008;168(12):1285–93.
Wilber JA, Barrow JG. Hypertension--a community problem. Am J Med. 1972;52(5):653–63.
Stamler J, Stamler R, Riedlinger WF, Algera G, Roberts RH. Hypertension screening of 1 million Americans. Community Hypertension Evaluation Clinic (CHEC) program, 1973 through 1975. JAMA. 1976;235(21):2299–306.
Blood pressure studies in 14 communities. A two-stage screen for hypertension. JAMA. 1977;237(22):2385–91.
Radice M, Alberti D, Alli C, Avanzini F, Di Tullio M, Mariotti G, et al. Long-term efficacy of screening for hypertension in a community. J Hypertens. 1985;3(3):255–9.
Cooke CJ, Meyers A. The Role of Community Volunteers in Health Interventions: a Hypertension Screening and Follow-Up Program. Am J Public Health. 1983;73(2):193–4.
Ambrosio GB, Strasser T, Dowd JE, Tuomilehto J, Nissinen A, Froment A, et al. Effects of Interventions on Community Awareness and Treatment of Hypertension: Results of a WHO Study. Bull World Health Organ. 1988;66(1):107–13.
Baird MG, Bentley-Taylor MM, Carruthers SG, Dawson KG, Laplante LE, Larochelle P, et al. A Study of Efficacy, Tolerance and Compliance of Once-Daily Versus Twice-Daily Metoprolol (Betaloc) in Hypertension. Betaloc Compliance Canadian Cooperative Study Group. Clin Invest Med. 1984;7(2):95–102.
Becker LA, Glanz K, Sobel E, Mossey J, Zinn SL, Knott KA. A Randomized Trial of Special Packaging of Antihypertensive Medications. J Fam Pract. 1986;22(4):357–61.
Brown BG, Bardsley J, Poulin D, Hillger LA, Dowdy A, Maher VM, et al. Moderate Dose, Three-Drug Therapy with Niacin, lovastatin, and Colestipol to Reduce Low-Density Lipoprotein Cholesterol <100 mg/dl in Patients with Hyperlipidemia and Coronary Artery Disease. Am J Cardiol. 1997;80(2):111–5.
Friedman RH, Kazis LE, Jette A, Smith MB, Stollerman J, Torgerson J, et al. A Telecommunications System for Monitoring and Counseling Patients with Hypertension. Impact on Medication Adherence and Blood Pressure Control. Am J Hypertens. 1996;9(4 Pt 1):285–92.
Girvin B, McDermott BJ, Johnston GD. A Comparison of Enalapril 20 mg Once Daily versus 10 mg Twice Daily in Terms of Blood Pressure Lowering and Patient Compliance. J Hypertens. 1999;17(11):1627–31.
Haynes RB, Sackett DL, Gibson ES, Taylor DW, Hackett BC, Roberts RS, et al. Improvement of Medication Compliance in Uncontrolled Hypertension. Lancet. 1976;1(7972):1265–8.
Johnson AL, Taylor DW, Sackett DL, Dunnett CW, Shimizu AG. Self-recording of Blood Pressure in the Management of Hypertension. Can Med Assoc J. 1978;119(9):1034–9.
Mosca L, Linfante AH, Benjamin EJ, Berra K, Hayes SN, Walsh BW, et al. National Study of Physician Awareness and Adherence to Cardiovascular Disease Prevention Guidelines. Circulation. 2005;111(4):499–510.
Hagemeister J, Schneider CA, Barabas S, Schadt R, Wassmer G, Mager G, et al. Hypertension Guidelines and Their Limitations--the Impact of Physicians' Compliance as Evaluated by Guideline Awareness. J Hypertens. 2001;19(11):2079–86.
Millett C, Gray J, Bottle A, Majeed A. Ethnic Disparities in Blood Pressure Management in Patients with Hypertension after the Introduction of Pay for Performance. Ann Fam Med. 2008;6(6):490–6.
Tsuyuki RT, Houle SKD, Charrois TL, Kolber MR, Rosenthal MM, Lewanczuk R, et al. A Randomized Trial of the Effect of Pharmacist Prescribing on Improving Blood Pressure in the Community: The Alberta Clinical Trial in Optimizing Hypertension (RxACTION). Circulation. 2015;132(2):93–100.
Victor RG. Expanding Pharmacists’ Role in the Era of Health Care Reform. Am J Health Syst Pharm. 2012;69(22):1959.
Jaffe MG, Lee GA, Young JD, Sidney S, Go AS. Improved Blood Pressure Control Associated with a Large-Scale Hypertension Program. JAMA. 2013;310(7):699–705.
Poulter NR, Prabhakaran D, Caulfield M. Hypertension. Lancet. 2015;386(9995):801–12.
Mullainthan S, Shafir E. Scarcity: Why Having so Little Means so Much. New York, Times Books, Henry Holt and Company, 2013.
Houle SK, McAlister FA, Jackevicius CA, Chuck AW, Tsuyuki RT. Does Performance-Based Remuneration for Individual Health Care Practitioners Affect Patient Care?: A Systematic Review. Ann Intern Med. 2012;157(12):889–99.
Volpp KG, Loewenstein G, Troxel AB, Doshi J, Price M, Laskin M, et al. A Test of Financial Incentives to Improve Warfarin Adherence. BMC Health Serv Res. 2008;8:272. doi: https://doi.org/10.1186/1472-6963-8-272
Ryan RM, Deci EL. Self-Determination Theory and the Facilitation of Intrinsic Motivation, Social Development, and Well-Being. Am Psychol. 2000;55(1):68–78.
Cialdini R. B., Eisenberg N. E., Green B. L., Rhoads K., Bator R. Undermining the Undermining Effect of Reward on Sustained Interest. J Appl Soc Psychol. 1998;28(3):249–63.
Victor RG, Haley RW, Willett DL, Peshock RM, Vaeth PC, Leonard D, et al. The Dallas Heart Study: a Population-Based Probability Sample for the Multidisciplinary Study of Ethnic Differences in Cardiovascular Health. Am J Cardiol. 2004;93(12):1473–80.
Victor RG, Ravenell JE, Freeman A, et al. Effectiveness of a Barber-Based Intervention for Improving Hypertension Control in Black Men: The barber-1 study: a Cluster Randomized Trial. Arch Intern Med. 2011;171(4):342–50.
Cote I, Gregoire JP, Moisan J, Chabot I. Quality of Life in Hypertension: the SF-12 Compared to the SF-36. Can J Clin Pharmacol = Journal Canadien de Pharmacologie Clinique. 2004;11(2):e232–8.
Fernandez S, Chaplin W, Schoenthaler AM, Ogedegbe G. Revision and Validation of the Medication Adherence Self-Efficacy Scale (MASES) in Hypertensive African Americans. J Behav Med. 2008;31(6):453–62.
Warren-Findlow J, Seymour RB, Brunner Huber LR. The Association Between Self-Efficacy and Hypertension Self-Care Activities Among African American Adults. J Commun Health. 2012;37(1):15–24.
Hibbard JH, Stockard J, Mahoney ER, Tusler M. Development of the Patient Activation Measure (PAM): Conceptualizing and Measuring Activation in Patients and Consumers. Health Serv Res. 2004;39(4 Pt 1):1005–26.
Crooks VC, Lubben J, Petitti DB, Little D, Chiu V. Social Network, Cognitive Function, and Dementia Incidence Among Elderly Women. Am J Public Health. 2008;98(7):1221–7.
Moser A, Stuck AE, Silliman RA, Ganz PA, Clough-Gorr KM. The Eight-Item Modified Medical Outcomes Study Social Support Survey: Psychometric Evaluation Showed Excellent Performance. J Clin Epidemiol. 2012;65(10):1107–16.
Cunningham WE, Andersen RM, Katz MH, Stein MD, Turner BJ, Crystal S, et al. The Impact of Competing Subsistence Needs and Barriers on Access to Medical Care for Persons with Human Immunodeficiency Virus Receiving Care in the United States. Med Care. 1999;37(12):1270–81.
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda, Maryland, United States Department of Health Services, National Institutes of Health, National Heart, Lung, and Blood Institute Publication No. 04–5230, 2004.
Tversky A, Kahneman D. Advances in Prospect Theory: Cumulative representation of Uncertainty. J Risk Uncertain. 1992;5(4):297–323.
American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. 2017 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2017, 23976; https://doi.org/10.1016/j.jacc.2017.07.74. Correction J Am Coll Cardiol 2018;71:e127–248.5
Worldwide Trends in Blood Pressure from 1975 to 2015: a Pooled Analysis of 1479 Population-Based Measurement Studies with 19·1 Million Participants. Lancet. 2017;389(10064):37–55.
VanEpps EM, Troxel AB, Villamil E, Saulsgiver KA, Zhu J, Chin J-Y, et al. Financial Incentives for Chronic Disease Management: Resultd and Limitations of 2 Randomized Clinical Trials With New York Medicaid Patioents. Am J Health Promot 2018;32(7):1537–43.
Mani A, Mullainathan S, Shafir E, Zhao J. Poverty Impedes Cognitive Function. Science 2013;341(6149):976–80.
Pocock SJ, Bakris G, Bhatt DL, Brar S, Fahy M, Bersh BJ. Regression to the mean in SYMPLICITY HTN-3. J Am Coll Cardiol. 2016;68(18):2016–2025.
Wilhelm M, Winkler A, Rief W, Doerning BK. Effect of placebo groups on blood pressure in hypertension: a meta-analysis of beta-blocker trials. J Am Soc Hypertension 2016;10(12):917–929.
Souza WK, Jardim PC, Brito LP, Araújo FA, Sousa AL. Self measurement of Blood Pressure for Control of Blood Pressure Levels and Adherence to Treatment. Arq Bras Cardiol. 2012;98(2):167–74.
Cahill K, Hartmann-Boyce J, Perera R. Incentives for smoking cessation. Cochrane Database Syst Rev. 2015;(5):CD004307.
Mantzari E, Vogt F, Shemilt I, Wei Y, Higgins JPT, Marteau TM. Personal financial incentives for changing habitual health-related behaviors: A systematic review and meta-analysis. Prev Med. 2015;75:75–85.
Thirumurthy H. Asch Da Volpp K: The uncertain effect of financial incentives to improve health behaviors. JAMA. 2019;25. https://doi.org/10.1001/jama.2019.2560.
Volpp KG, Troxel AB, Mehta SJ et al. Effect of electronic reminders, financial incentives, and social support on outcomes after myocardial infarction. JAMA Intern Med. 2017;177(8):1093–1101
Liu T, Volpp KG, Asch DA. The association of financial incentives for low density lipoprotein cholesterol reduction with patient activation and motivation. Prev Med Rep. 2019;14:100841. doi: https://doi.org/10.1016/j.pmedr.2019.100841.
Asch DA, Troxel AB, Stewart WF et al. Effect of financial incentives to physicians, patients, or both on lipid levels. A randomized trial. JAMA. 2015;314(18):1926–35
Sen AP, Sewell TB, Riley EB et al. Financial incentives for home-based health monitoring. A randomized trial. J Gen Intern Med. 2014; 29(5):770–7
Czaicki NL, Dow WH, Njau PF, McCoy SI. Do incentives undermine intrinsic motivation? Increases in motivation within an incentive-based intervention for people living with HIV in Tanzania. PLOS One. 2018. Available at: https://doi.org/10.1371/journal.pone.0196616. Accessed July 10, 2019.
Promberger M, Marteau TM. When do financial incentives reduce intrinsic motivation? Comparing behaviors in psychological and economic literature. Health Psychol. 2013;32(9):950–7
Murayama K, Matsumoto M, Izuma K, Matdsumoto K. Neural basis of the undermining effect of monetary reward on intrinsic motivation. PNAS. 2010; 107(49):20911–6
Shah N. Introduction. In Cohen IG, Lynch HF, Robertson CT (eds). Nudging Health: Health Law and Behavioral Economics. Baltimore, Johns Hopkins University Press 2016:187–9.
Underhill K. Extrinsic incentives, intrinsic motivation, and motivational crowding out in health law and policy. In Cohen IG, Lynch HF, Robertson CT (eds). Nudging Health: Health Law and Behavioral Economics. Baltimore, Johns Hopkins University Press 2016:190–201.
Sen AP, Hffman D, Loewenstein G, Asch DA, Kullgren JT, Volpp KG. Do financial incentives reduce intrinsic motivation for weight loss? Underhill K. Extrinsic incentives, intrinsic motivation, and motivational crowding out in health law and policy. In Cohen IG, Lynch HF, Robertson CT (eds). Nudging Health: Health Law and Behavioral Economics. Baltimore, Johns Hopkins University Press 2016:202–16.
Drawz PE, Pajewski NM, Bates JT, et al. Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT Ambulatory Blood Pressure Study. Hypertension. 2017;69(1):42–50.
Victor RG, Lynch K, Li N, et al. A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops. N Engl J Med. 2018;378(14)1291–1301.